Researcher profile

Genke Yang

Genke Yang contributes to research discovery and scholarly infrastructure.

ResearcherAffiliation not importedOpen to collaborate

Trust snapshot

Quick read

Trust 17 - UnverifiedVerification L1Unclaimed author
4works
0followers
6topics
3close collaborators

Actions

Decide how to stay connected

Follow researcher0

Identity and collaboration

How to connect with this researcher

Claiming links this public author record to a researcher profile and unlocks direct collaboration workflows.

Log in to claim

Direct collaboration

Open a focused conversation when the fit is right

Claim this author entity first to unlock direct invitations.

Research graph

See the researcher in context

Open full explorer

Inspect adjacent work, topics, institutions and collaborators without jumping out to a separate graph page.

Building this graph slice

BZPEER is loading the nearby papers, people, topics and institutions for this page.

Published work

4 published item(s)

preprint2026arXiv

Text-Video Retrieval With Global-Local Contrastive Consistency Learning

Text-video retrieval aims to find the most semantically similar videos with given text queries. However, since videos contain more diverse content than texts, the main semantics expressed by each text-video pair is often partially relevant. The primary methods involve the utilization of language-video attention module to align texts and videos. Though effective, this paradigm inevitably introduces prohibitive computational overhead, resulting in inefficient retrieval. In this paper, we propose a simple yet effective method called Global-Local Contrastive Consistency Learning (GLCCL) to achieve texts and videos semantics alignment. Specifically, we design a parameter-free Global-Local Interaction Module (GLIM) to generate semantic-related frame and video features in a text-guided manner. Furthermore, a Contrastive Score Consistency (CSC) loss is developed to promote consistency learning among different scores on positive pairs and suppress consistency learning on negative pairs. Empirical evidence suggests that CSC loss provides the model with robust discriminative power between positives and hard negatives. Extensive experiments on three benchmark datasets, including MSR-VTT, DiDeMo and VATEX, demonstrate the effectiveness and superiority of our approach.

preprint2023arXiv

The Balanced Matrix Factorization for Computational Drug Repositioning

Computational drug repositioning aims to discover new uses of drugs that have been marketed. However, the existing models suffer from the following limitations. Firstly, in the real world, only a minority of diseases have definite treatment drugs. This leads to an imbalance in the proportion of validated drug-disease associations (positive samples) and unvalidated drug-disease associations (negative samples), which disrupts the optimization gradient of the model. Secondly, the existing drug representation does not take into account the behavioral information of the drug, resulting in its inability to comprehensively model the latent feature of the drug. In this work, we propose a balanced matrix factorization with embedded behavior information (BMF) for computational drug repositioning to address the above-mentioned shortcomings. Specifically, in the BMF model, we propose a novel balanced contrastive loss (BCL) to optimize the category imbalance problem in computational drug repositioning. The BCL optimizes the parameters in the model by maximizing the similarity between the target drug and positive disease, and minimizing the similarity between the target drug and negative disease below the margin. In addition, we designed a method to enhance drug representation using its behavioral information. The comprehensive experiments on three computational drug repositioning datasets validate the effectiveness of the above improvement points. And the superiority of BMF model is demonstrated by experimental comparison with seven benchmark models.

preprint2022arXiv

Self-supervised Learning for Label Sparsity in Computational Drug Repositioning

The computational drug repositioning aims to discover new uses for marketed drugs, which can accelerate the drug development process and play an important role in the existing drug discovery system. However, the number of validated drug-disease associations is scarce compared to the number of drugs and diseases in the real world. Too few labeled samples will make the classification model unable to learn effective latent factors of drugs, resulting in poor generalization performance. In this work, we propose a multi-task self-supervised learning framework for computational drug repositioning. The framework tackles label sparsity by learning a better drug representation. Specifically, we take the drug-disease association prediction problem as the main task, and the auxiliary task is to use data augmentation strategies and contrast learning to mine the internal relationships of the original drug features, so as to automatically learn a better drug representation without supervised labels. And through joint training, it is ensured that the auxiliary task can improve the prediction accuracy of the main task. More precisely, the auxiliary task improves drug representation and serving as additional regularization to improve generalization. Furthermore, we design a multi-input decoding network to improve the reconstruction ability of the autoencoder model. We evaluate our model using three real-world datasets. The experimental results demonstrate the effectiveness of the multi-task self-supervised learning framework, and its predictive ability is superior to the state-of-the-art model.

preprint2022arXiv

The Computational Drug Repositioning without Negative Sampling

Computational drug repositioning technology is an effective tool to accelerate drug development. Although this technique has been widely used and successful in recent decades, many existing models still suffer from multiple drawbacks such as the massive number of unvalidated drug-disease associations and the inner product. The limitations of these works are mainly due to the following two reasons: firstly, previous works used negative sampling techniques to treat unvalidated drug-disease associations as negative samples, which is invalid in real-world settings; secondly, the inner product cannot fully take into account the feature information contained in the latent factor of drug and disease. In this paper, we propose a novel PUON framework for addressing the above deficiencies, which models the risk estimator of computational drug repositioning only using validated (Positive) and unvalidated (Unlabelled) drug-disease associations without employing negative sampling techniques. The PUON also proposed an Outer Neighborhood-based classifier for modeling the cross-feature information of the latent facotor. For a comprehensive comparison, we considered 8 popular baselines. Extensive experiments in four real-world datasets showed that PUON model achieved the best performance based on 6 evaluation metrics.